Graeme Milligan



Biography: Graeme Milligan Ph.D., FBPharmacolS, FRSE, FMedSci Education/Training 1976-1979: University of Birmingham: Graduated with B.Sc. (Hons. 1st class) Biochemistry. 1979-1982: University of Nottingham: Graduated with Ph.D. 1982-1985: Fogarty International Visiting Fellow, National Institute of Mental Health Bethesda, MD. U.S.A. Current Positions 1994-present: Professor of Molecular Pharmacology, University of Glasgow, Glasgow, Scotland, U.K. 2010-present: Dean of Research, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, U.K. 2012-present: Gardiner Professor of Biochemistry, University of Glasgow, Glasgow, Scotland, U.K. I was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and of the Academy of Medical Sciences in 2016. I was awarded the JR Vane Medal for Pharmacology in 2016 by the British Pharmacological Society. I co-founded Caldan Therapeutics ( in 2015 and licensed technologies that promoted the start-up of both Cara Therapeutics ( (in 2004) and Arena Pharmaceutics ( )(in 1997). My main research group centres on the function, structure and regulation of G protein-coupled receptors (GPCRs) and their interacting proteins. I have published more than 500 peer-reviewed articles on these topics. My research has been cited more than 22,000 times and I am a Thompson Reuters 2014 and 2016 Highly Cited Researcher (

Record last modified Oct 16, 2018 10:13:03 AM